# FDA Inspection 1235116 - Alkaloids Private Ltd - February 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/alkaloids-private-ltd/e8f022c2-a05e-4ce5-a71a-62c990a0c7e8
Source feed: FDA_Inspections

> FDA Inspection 1235116 for Alkaloids Private Ltd on February 23, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235116
- Company Name: Alkaloids Private Ltd
- Inspection Date: 2024-02-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 975801 - 2016-06-09](https://www.keypedia.com/records/fda_inspections/alkaloids-private-ltd/07b381c1-2fef-4119-857a-7253f5078a85)
- [FDA Inspection 724800 - 2011-02-25](https://www.keypedia.com/records/fda_inspections/alkaloids-private-ltd/7d7f6c17-fff4-4340-b682-81c53abfefca)

Company: https://www.keypedia.com/companies/alkaloids-private-ltd/768cf5f2-4c3b-4451-97f1-dcaf8f9498e3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c